Biodesix annual depreciation and amortization
2019
2020
2021
2022
2023
2024
2025
Biodesix Depreciation & Amortization Growth & History (BDSX)
Biodesix's depreciation and amortization was $5.7M for fiscal 2025.
View full Biodesix company overviewBiodesix annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $5.7M | −$103,000 | −1.78% |
| 2024 | 2024-12-31 | $5.8M | $2.4M | +73.47% |
| 2023 | 2023-12-31 | $3.3M | −$269,000 | −7.48% |
| 2022 | 2022-12-31 | $3.6M | $419,000 | +13.18% |
| 2021 | 2021-12-31 | $3.2M | $275,000 | +9.47% |
| 2020 | 2020-12-31 | $2.9M | $110,000 | +3.94% |
| 2019 | 2019-12-31 | $2.8M | — | — |
Biodesix quarterly depreciation and amortization
Q3.19
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.4M | −$51,000 | −3.55% |
| Q1 2026 | 2026-03-31 | $1.4M | −$44,000 | −3.06% |
| Q4 2025 | 2025-12-31 | $1.4M | — | — |
| Q3 2025 | 2025-09-30 | $1.4M | −$87,000 | −5.83% |
| Q2 2025 | 2025-06-30 | $1.4M | $25,000 | +1.77% |
| Q1 2025 | 2025-03-31 | $1.4M | $20,000 | +1.41% |
| Q3 2024 | 2024-09-30 | $1.5M | $711,000 | +90.92% |
| Q2 2024 | 2024-06-30 | $1.4M | $628,000 | +80.10% |
| Q1 2024 | 2024-03-31 | $1.4M | $635,000 | +80.89% |
| Q3 2023 | 2023-09-30 | $782,000 | −$111,000 | −12.43% |
| Q2 2023 | 2023-06-30 | $784,000 | −$114,000 | −12.69% |
| Q1 2023 | 2023-03-31 | $785,000 | −$123,000 | −13.55% |
| Q3 2022 | 2022-09-30 | $893,000 | $93,000 | +11.63% |
| Q2 2022 | 2022-06-30 | $898,000 | $121,000 | +15.57% |
| Q1 2022 | 2022-03-31 | $908,000 | $162,000 | +21.72% |
| Q3 2021 | 2021-09-30 | $800,000 | $17,000 | +2.17% |
| Q2 2021 | 2021-06-30 | $777,000 | $64,000 | +8.98% |
| Q1 2021 | 2021-03-31 | $746,000 | $68,000 | +10.03% |
| Q3 2020 | 2020-09-30 | $783,000 | $83,000 | +11.86% |
| Q2 2020 | 2020-06-30 | $713,000 | — | — |
| Q1 2020 | 2020-03-31 | $678,000 | — | — |
| Q3 2019 | 2019-09-30 | $700,000 | — | — |
Biodesix depreciation and amortization trends
Over the last five fiscal years, Biodesix's depreciation and amortization increased from $2.9M to $5.7M, a change of $2.8M. The latest reported quarter, Q2 2026, shows $1.4M.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Biodesix source filings ↗